TİTCK Updates FAQ And COVID-19 Measures Documents For Clinical Trials

Recent Development

On July 25, 2020, the Turkish Medicine and Medical Devices Authority ("TITCK") updated its Frequently Asked Questions (FAQ) document and COVID-19 measures document regarding clinical trials. The TITCK's relevant announcements and updated documents are available online here (in Turkish).

What's New?

The TITCK updated the application procedures for clinical trial meetings held online during the pandemic:

• The 30-day period for meeting applications filed with the TITCK will now be five business days. In other words, applicants must file their meeting applications to the TITCK within five business days before the meeting date.
• The applicants will be able to file meeting applications with the TITCK for clinical trials that are not officially approved by the Ethics Committee or the TITCK. However, for these applications, the applicants must submit a copy of the cover letter relating to the initial application to the Ethics Committee.